NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/07/2026
Voltar para busca
Dado oficial do USPTO
ELEVIVA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ELEVIVA
ST13
US500000079392168Classe
3, 5, 10, 42, 44
Pedido
79392168
Registro
7574974
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
09/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 10, 42, 44
Data de depósito
15/12/2023
Data de registro
26/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/11/2024
Última transação
09/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IE
Examinador
JANSON, ANDREW KYLE
Unidade examinadora
L50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Bausch Health Ireland Limited
Representantes
Jeremy Blackowicz Bausch Health Companies
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Non-medicated skin care preparations; non-medicated oral care preparations; non-medicated oral hygiene preparationstoothpastemouthwashdental rinse; cosmetics
Classe 5
pharmaceutical products and medicines for human use for prevention and treatment of allergicautoimmunebronchialbonecancercardiovascularcentral nervous systemdermatologicalendocrinegastrointestinalgenitourinarygynecologicalhematologicalhepatologicalimmunologicalinfectiousinflammatorymentalmetabolicmusculoskeletalnephrologicalneurologicalneuromuscularoncologicalophthalmicoralpainpsychiatricpulmonaryrenalrespiratoryurologicalviral diseases and disorders; Pharmaceutical products and medicines for human use for colonoscopies and endoscopic procedures; medicated skin care preparations; medicated oral care preparations; nutritional supplements; dietetic supplementsdietetic preparations adapted for medical purposes; vitamins
Classe 10
Surgical apparatus and instruments; medical apparatus for the delivery and release of pharmaceuticalsdrug delivery patches sold without medicationinhalers for medical use sold emptyintravenous bags sold empty for intravenous therapysyringes; medical devices for non-surgical cosmetic skin treatments; lasers for the medical treatment of the face and skin; radiofrequency therapy apparatus for the medical and cosmetic treatment of the face and skinin particular for contracting skinsmoothing fine lines and wrinkles on skinbody sculptingsoft tissue reconstruction in a non-invasive manner; high frequency electromagnetic wave therapeutic instruments; liposuction apparatus; medical radiofrequencylaserultrasound therapy apparatus for the treatment of cellulite; medical apparatus and instruments for body toning and body shaping
Classe 42
Pharmaceutical research and development; medical and scientific researchconducting clinical trials for pharmaceutical products for others; testing of pharmaceuticals; providing medical and scientific research information on the field of pharmaceuticals and clinical trials; conducting early evaluations in the field of new pharmaceuticals; developments of pharmaceutical drug delivery systems; product research and development services for others in the field of beautywellnesshealth care products
Classe 44
Providing medical and health information to consumers and healthcare professionals regarding pharmaceutical products; medical information servicesproviding medical and healthcare information regarding prescription drugs and disease treatment; providing medical and health information to consumers and healthcare professionals regarding medical aesthetics treatments and procedures; providing medical and health information to consumers and healthcare professionals regarding dental treatmentdental hygieneoral health; providing information in the fields of healthwellness; performing non-invasive cosmetic medical procedures; medical clinic servicescosmetic and therapeutic skin and body care treatment; laser skin rejuvenation service; laser skin tightening service
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/09/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/08/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/05/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/04/2025
FIMP
FINAL DISPOSITION PROCESSED
24/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
26/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/09/2024
PUBO
PUBLISHED FOR OPPOSITION
24/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2024
RFNT
REFUSAL PROCESSED BY IB
25/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/08/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
16/08/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/08/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
16/08/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/08/2024
RFRR
REFUSAL PROCESSED BY MPU
05/08/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/07/2024
CNRT
NON-FINAL ACTION WRITTEN
15/07/2024
DOCK
ASSIGNED TO EXAMINER
15/07/2024
MAFR
APPLICATION FILING RECEIPT MAILED
02/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/03/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/03/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ELEVIVA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.